Model-fitting and linkage analysis of sodium-lithium countertransport

European Journal of Human Genetics

Volumn 12, Issue 12, 2004, Pages 1055-1061

  Hasstedt, Sandra J ^a   Camp, Nicola J ^a   Hopkins, Paul N ^a   Coon, Hilary ^a   McKinney, Jason T ^b,c   Cawthon, Richard M ^a   Hunt, Steven C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Idaho Technology Inc   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

Genetics; Likelihood analysis; Linkage analysis

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; ANTIPORTER; APOLIPOPROTEIN E2; GLYCINE; SODIUM LITHIUM EXCHANGE PROTEIN; TRIACYLGLYCEROL; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; INHERITANCE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PEDIGREE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIPORTERS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; LINKAGE (GENETICS); LITHIUM; LOD SCORE; MALE; MIDDLE AGED; MODELS, GENETIC; SODIUM;

EID: 10044254236     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201262     Document Type: Article

References (45)

1. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980; 302: 772-776.
2. + countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review. Eur J Clin Invest 1998; 28: 339-352.
3. Dadone MM, Hasstedt SJ, Hunt SC, Smith JB, Ash KO, Williams RR: Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds. Am J Med Genet 1984; 17: 565-577.
4. Hasstedt SJ, Wu LL, Ash KO, Kuida H, Williams RR: Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for major-locus inheritance. Am J Hum Genet 1998; 43 14-22.
5. 3-adrenergic receptor in essential hypertension. Life Sci 2000; 67: 391-397.
6. Glorioso N, Filigheddu F, Cusi D et al: α-Adducin 460Trp allele is associated with erythrocyte Na transport rate in north Sardinian primary hypertensives. Hypertension 2002; 39: 357-362.
7. Grant FD, Romero JR, Jeunemaitre X et al: Low-renin hypertension, altered sodium homeostasis, and an α-adducin polymorphism. Hypertension 2002; 39: 191-196.
8. + countertransport. J Am Soc Nephrol 1991; 2: 937-943.
9. + antiporter as a candidate gene in human essential hypertension. Hypertension 1991; 17: 8-14.
10. Tournoy KG, Delanghe JR, Duprez DA et al: Genetic polymorphisms and erythrocyte sodium-lithium countertransport in essential hypertension. Clin Chim Acta 1996; 255: 39-55.
11. Hardman TC, Wierzbicki AS, Croft P, Feher M, Cox A, Lant AF: Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension. J Hum Hypertens 1997; 11: 251-252.
12. 3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension. Br J Biomed Sci 2002; 59: 101-104.
13. Weder AB, Schork NJ, Julius S: Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Hypertension 1991; 17: 977-981.
14. Stiefel P, Montilla C, Muniz-Grijalvo O et al: Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodium-lithium countertransport activity in essential hypertension. Metabolism 2001; 40: 157-160.
15. Wierzbicki AS, Hardman TC, Cheung J et al: The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter. Am J Hypertens 2002; 15: 633-637.
16. Weder AB, Delgado MC, Zhu X, Gleiberman L, Kan D, Chakravarti A: Erythrocyte sodium-lithium countertransport and blood pressure: a genome-wide linkage study. Hypertension 2003; 41: 842-846.
17. Kammerer CM, Cox LA, Mahaney MC, Rogers J, Shade RE: Sodium-lithium countertransport activity is linked to chromosome 5 in baboons. Hypertension 2001; 37: 398-402.
18. Schork NJ, Gardner JP, Zhang L et al: Genomic association/linkage of sodium lithium countertransport in CEPH pedigrees. Hypertension 2002; 40: 619-628.
19. Williams RR, Hunt SC: Recruitment of members of high-risk Utah pedigrees. Control Clin Trials 1987; 8: 105S-114S.
20. Smith JB, Price AL, Williams RR et al: A reproducible sodium-lithium countertransport assay: the outcome of changing key laboratory parameters. Clin Chim Acta 1982; 122: 327-335.
21. Weber JL, Broman KW: Genotyping for human whole-genome scans: past, present, and future. Adv Genet 2001; 42: 77-96.
22. Hunt SC, Hasstedt SJ, Coon H et al: Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat. Kidney Int 2002; 62: 1143-1148.
23. Sobel E, Lange K: Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996; 58: 1323-1337.
24. Sobel E, Papp JC, Lange K: Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 2002; 70: 496-508.
25. Mukhopadhyay N, Almasy L, Schroeder M, Mulvihill WP, Weeks DE: Mega2, a data-handling program for facilitating genetic linkage and association analyses. Am J Hum Genet 1999; 65: A436.
26. Hasstedt SJ PAP: Pedigree Analysis Package, Ver. 5. Department of Human Genetics, University of Utah, 2002.
27. Hasstedt SJ: A variance components/major locus likelihood approximation for quantitative, polychotomous, and multivariate data. Genet Epidemiol 1993; 10: 145-158.
28. Hasstedt SJ, Hoffman M, Leppert MF, Elbein SC: Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes. Am J Hum Genet 1997; 61: 668-677.
29. Bray MS, Li L, Turner ST, Kardia SL, Boerwinkle E: Association and linkage analysis of the α-adducin gene and blood pressure. Am J Hypertens 2000; 13: 699-703.
30. Wang JG, Staessen JA, Barlassina C et al: Association between hypertension and variation in the α- and β-adducin genes in a white population. Kidney Int 2002; 62: 2152-2159.
31. Mahley RW, Rall Jr SC: Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537.
32. Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
33. Hunt SC, Williams RR, Ash KO: Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 21/2 years of follow-up in Utah. Cardiovasc Drugs Ther 1990; 4 (Suppl 2): 357-362.
34. Cirillo M, Laurenzi M, Panarelli W, Trevisan M, Stamler J: Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Population Study Research Group. Hypertension 1999; 33: 887-893.
35. Herlitz H, Bokemark L, Alenhag EL, Wikstrand J, Fagerberg B: Sodium/lithium countertransport, insulin resistance, insulin peptides and microalbuminuria in clinically healthy 58-year-old men. Clin Sci 2001; 100: 443-449.
36. Ferri C, Bellini C, Desideri G et al: Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk. Diabetes 1999; 48: 1623-1630.
37. Hardman TC, Lant AF: Controversies surrounding erythrocyte sodium-lithium countertransport. J Hypertens 1996; 14: 1153-1154.
38. Rutherford PA, Thomas TH, Laker MF, Wilkinson R: Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension. Eur J Clin Invest 1992; 22: 719-724.
39. Carr SJ, Thomas TH, Laker MF, Wilkinson R: Lipid lowering therapy leads to a reduction in sodium-lithium countertransport activity. Atherosclerosis 1991; 87: 103-108.
40. Messner H, Kleophas W, Hein D, Gries FA, Kobberling J: Sodium lithium countertransport is acutely influenced by heparin-induced extracorporal LDL precipitation. Eur J Clin Invest 1991; 21: 215-218.
41. Rutherford PA, Thomas TH, Wilkinson R: Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium. Clin Sci 1990; 79: 365-369.
42. Wolpert HA, Steen SN, Istfan NW, Simonson DC: Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activity. Am J Hypertens 1992; 5 754-757.
43. Hasstedt SJ, Hunt SC, Wu LL, Williams RR: Evidence for multiple genes determining sodium transport. Genet Epidemiol 1994; 11: 553-568.
44. Marquet S, Abel L, Hillaire D et al: Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 1996; 14: 181-184.
45. Xu J, Bleecker ER, Jongepier H et al: Major recessive gene(s) with considerable residual polygenic effect regulating adult height: confirmation of genomewide scan results for chromosomes 6, 9, and 12. Am J Hum Genet 2002; 71: 646-650.